Search - tctmd.com

Displaying 1 - 20 of 93

Sort: Relevancy | Date

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

Presentation TCT 2016

Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road?

Presenter: Fernando Alfonso, Juan F. Granada

November 01, 2016

Presentation TCT 2016

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

Presenter: Fernando Alfonso, Juan F. Granada, Azeem Latib

November 01, 2016

Presentation TCT 2016

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

Presenter: Fernando Alfonso, Juan F. Granada, Bernardo Cortese

November 01, 2016

Presentation TCT 2016

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

November 01, 2016

Presentation TCT 2016

Designing a Complication-Free DCB: Is It Possible or Necessary?

Presenter: Koen Deloose, William A. Gray, Juan F. Granada

November 01, 2016

Presentation TCT 2016

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Presenter: Koen Deloose, William A. Gray, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Presenter: Koen Deloose, William A. Gray, Lawrence A. Garcia

November 01, 2016

Presentation TCT 2016

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

Presenter: Koen Deloose, William A. Gray

November 01, 2016

Presentation TCT 2016

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Presenter: Koen Deloose, William A. Gray, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Presenter: Koen Deloose, William A. Gray, Kenneth Rosenfield

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Presenter: Koen Deloose, William A. Gray, John R. Laird Jr.

November 01, 2016

Presentation TCT 2016

Overview of the Clinical Trials for Drug-Coated Balloons

Presenter: Schuyler Jones, Misti Malone, George Papandreou

October 30, 2016

Presentation TCT 2015

The Technological Evolution of Local Drug Delivery: Implications for the Clinical Adoption of Coronary DCBs

Presenter: Juan F. Granada, Bruno Scheller

October 13, 2015

Presentation TCT 2015

Life After the RIBS Trials: A Critical Overview of the Data and Implications for Clinical Practice

Presenter: Juan F. Granada, Bruno Scheller, Fernando Alfonso

October 13, 2015

Presentation TCT 2015

DCB for ISR Treatment: Technical Considerations for Optimization of Clinical Outcomes

Presenter: Juan F. Granada, Bruno Scheller, Pieter R. Stella

October 13, 2015

Presentation TCT 2015

The Promise of Vascular Restoration Therapy for De Novo Lesions: Technique, Limitations, and Clinical Data

Presenter: Juan F. Granada, Bruno Scheller

October 13, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Presenter: Gary M. Ansel, J. A. Mustapha, Ron Waksman

October 12, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Presenter: Gary M. Ansel, J. A. Mustapha, Francesco Liistro

October 12, 2015

Advertisement

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road?

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Designing a Complication-Free DCB: Is It Possible or Necessary?

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Overview of the Clinical Trials for Drug-Coated Balloons

The Technological Evolution of Local Drug Delivery: Implications for the Clinical Adoption of Coronary DCBs

Life After the RIBS Trials: A Critical Overview of the Data and Implications for Clinical Practice

DCB for ISR Treatment: Technical Considerations for Optimization of Clinical Outcomes

The Promise of Vascular Restoration Therapy for De Novo Lesions: Technique, Limitations, and Clinical Data

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content